Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,283 | 523 | 98.7% |
| Education | $110.91 | 3 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,271 | 90 | $0 (2024) |
| Astellas Pharma US Inc | $777.80 | 42 | $0 (2021) |
| ABBVIE INC. | $631.19 | 42 | $0 (2024) |
| Lilly USA, LLC | $605.45 | 40 | $0 (2024) |
| PFIZER INC. | $565.05 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $553.81 | 36 | $0 (2024) |
| Amgen Inc. | $519.00 | 34 | $0 (2024) |
| GlaxoSmithKline, LLC. | $362.69 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $356.86 | 22 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $318.16 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,626 | 99 | Lilly USA, LLC ($256.36) |
| 2023 | $1,150 | 66 | AbbVie Inc. ($215.11) |
| 2022 | $878.66 | 57 | Bayer HealthCare Pharmaceuticals Inc. ($145.57) |
| 2021 | $1,197 | 75 | Novo Nordisk Inc ($218.45) |
| 2020 | $791.96 | 55 | Novo Nordisk Inc ($162.23) |
| 2019 | $931.23 | 62 | Novo Nordisk Inc ($225.43) |
| 2018 | $994.34 | 64 | Astellas Pharma US Inc ($212.08) |
| 2017 | $824.21 | 48 | Astellas Pharma US Inc ($185.24) |
All Payment Transactions
526 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: PAIN | ||||||
| 11/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.61 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: PAIN | ||||||
| 11/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: UROLOGY | ||||||
| 10/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.43 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: PAIN | ||||||
| 10/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Diabetes | ||||||
| 10/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.72 | General |
| 09/30/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 2,894 | 4,390 | $317,837 | $116,424 |
| 2022 | 41 | 2,713 | 4,411 | $329,796 | $129,560 |
| 2021 | 40 | 3,053 | 4,766 | $336,671 | $129,206 |
| 2020 | 35 | 2,814 | 4,411 | $320,722 | $114,177 |
All Medicare Procedures & Services
158 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 273 | $37,509 | $19,105 | 50.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 114 | 114 | $20,520 | $13,364 | 65.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 164 | 206 | $19,455 | $10,059 | 51.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 34 | 207 | $15,525 | $9,095 | 58.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 58 | $11,040 | $5,910 | 53.5% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 61 | $9,150 | $5,721 | 62.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 31 | 167 | $12,525 | $5,635 | 45.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 96 | $9,120 | $5,562 | 61.0% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 21 | 81 | $12,150 | $4,103 | 33.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 18 | $7,200 | $3,588 | 49.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 65 | 70 | $8,750 | $3,466 | 39.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 109 | 119 | $27,965 | $3,452 | 12.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 126 | 157 | $10,990 | $2,584 | 23.5% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2023 | 125 | 152 | $15,200 | $2,113 | 13.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 119 | 133 | $9,310 | $1,966 | 21.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 149 | 226 | $3,390 | $1,898 | 56.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 118 | 143 | $10,725 | $1,876 | 17.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 138 | 164 | $12,300 | $1,694 | 13.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $2,200 | $1,658 | 75.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 64 | 79 | $5,530 | $1,424 | 25.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 126 | 153 | $7,650 | $1,353 | 17.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 136 | 166 | $8,300 | $1,257 | 15.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 61 | 114 | $5,700 | $1,085 | 19.0% |
| 82977 | Glutamyltransferase (liver enzyme) level | Office | 2023 | 115 | 131 | $2,882 | $924.86 | 32.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 48 | 49 | $2,072 | $912.50 | 44.0% |
About Dr. Kevin Webster, M.D
Dr. Kevin Webster, M.D is a Internal Medicine healthcare provider based in Carrollton, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861483638.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Webster, M.D has received a total of $8,393 in payments from pharmaceutical and medical device companies, with $1,626 received in 2024. These payments were reported across 526 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($8,283).
As a Medicare-enrolled provider, Webster has provided services to 11,474 Medicare beneficiaries, totaling 17,978 services with total Medicare billing of $489,367. Data is available for 4 years (2020–2023), covering 158 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Carrollton, GA
- Active Since 11/02/2005
- Last Updated 11/21/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1861483638
Products in Payments
- Ozempic (Drug) $657.86
- MYRBETRIQ (Drug) $549.59
- REXULTI (Drug) $418.87
- JARDIANCE (Drug) $307.97
- Kerendia (Drug) $302.02
- ELIQUIS (Drug) $301.34
- XIFAXAN (Drug) $276.49
- BREZTRI (Drug) $242.59
- Aimovig (Biological) $235.34
- MOUNJARO (Drug) $209.91
- FARXIGA (Drug) $203.40
- VOQUEZNA (Drug) $190.26
- Rybelsus (Drug) $182.84
- UBRELVY (Drug) $176.87
- VRAYLAR (Drug) $170.04
- TRULICITY (Drug) $163.63
- SHINGRIX (Biological) $157.49
- Saxenda (Drug) $152.12
- TRELEGY ELLIPTA (Drug) $151.66
- PENNSAID (Drug) $149.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Carrollton
Lindsey Roenigk, Md, MD
Internal Medicine — Payments: $15,235
Joseph Murphy, Md, MD
Internal Medicine — Payments: $13,676
Dr. Joanne Gaw, M.d, M.D
Internal Medicine — Payments: $11,919
Dr. William Berard, M.d, M.D
Internal Medicine — Payments: $11,084
Dr. Ketan Patel, M.d, M.D
Internal Medicine — Payments: $9,726
Dr. Cesar Aleman, M.d, M.D
Internal Medicine — Payments: $7,951